Physician profile
Renee Dua
NPI 1154436707
$997.01
in general payments reported to CMS, 2019-2025
10 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.56 · 2022: $31.31 · 2023: $519 · 2024: $197 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $826.15 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $264.53 | 2023-2024 | Acthar |
| Glaxosmithkline, LLC. | $174.77 | 2022-2024 | Benlysta, Jesduvroq |
| Akebia Therapeutics INC | $131.48 | 2024-2025 | Vafseo |
| Astrazeneca Pharmaceuticals Lp | $94.19 | 2021-2024 | Farxiga |
| Calliditas Therapeutics US INC. | $88.01 | 2023-2024 | Tarpeyo |
| Novartis Pharmaceuticals Corporation | $73.43 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.65 | 2023-2024 | Jardiance |
| Travere Therapeutics, INC. | $48.01 | 2021-2023 | |
| Ani Pharmaceuticals, INC. | $30.99 | 2025 | Purified Cortrophin Gel |
| Amgen INC. | $28.95 | 2024 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Dua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.